Core Viewpoint - The independent directors of Renfu Pharmaceutical Group Co., Ltd. held their first special meeting in 2025, where they unanimously approved several proposals related to a financial service agreement with China Merchants Group Finance Co., Ltd. [1][2] Group 1: Financial Service Agreement - The proposed financial service agreement with China Merchants Group Finance Co., Ltd. adheres to principles of equality and voluntariness, with fair pricing that is beneficial for expanding the company's financing channels [1] - The decision-making process for the related party transaction complies with relevant laws and regulations, as well as the company's articles of association, ensuring no harm to the interests of the company and its shareholders, particularly minority shareholders [1] Group 2: Risk Assessment Report - The risk assessment report regarding China Merchants Group Finance Co., Ltd. is deemed objective and fair, accurately reflecting the financial company's operational qualifications, business, and risk status [2] - The report is approved for submission to the company's board of directors for further review [2] Group 3: Risk Disposal Plan - The risk disposal plan formulated for conducting financial business with China Merchants Group Finance Co., Ltd. is designed to effectively prevent, control, and mitigate risks associated with the financial operations, ensuring the safety of the company's funds [2] - This plan is also approved for submission to the company's board of directors for further consideration [2]
人福医药: 人福医药第十一届董事会独立董事2025年第一次专门会议决议